Back to search

Article

Ensovibep, a novel trispecific DARPin candidate that protects against SARS-CoV-2 variants

2021-12-20

Abstract excerpt

<title>Abstract</title> <p>SARS-CoV-2 has infected millions of people globally and continues to undergo evolution. Emerging variants can be partially resistant to vaccine induced and therapeutic antibodies, emphasizing the urgent need for accessible, broad-spectrum therapeutics. Here, we report a comprehensive study of ensovibep, the first trispecific clinical DARPin candidate, that can simultaneously engage all...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3e231db4-bdf8-52b8-b7d1-91595bc8a4a0
DOI
10.21203/rs.3.rs-1170399/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Ensovibep, a novel trispecific DARPin candidate that protects against SARS-CoV-2 variantsDOI 10.21203/rs.3.rs-1170399/v1
Select a neighboring publication to make it the new centre.